MX2020004949A - Arn no codificante para la deteccion de cancer. - Google Patents
Arn no codificante para la deteccion de cancer.Info
- Publication number
- MX2020004949A MX2020004949A MX2020004949A MX2020004949A MX2020004949A MX 2020004949 A MX2020004949 A MX 2020004949A MX 2020004949 A MX2020004949 A MX 2020004949A MX 2020004949 A MX2020004949 A MX 2020004949A MX 2020004949 A MX2020004949 A MX 2020004949A
- Authority
- MX
- Mexico
- Prior art keywords
- detection
- cancer
- coding rna
- sample
- noncoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762584899P | 2017-11-12 | 2017-11-12 | |
| PCT/US2018/060113 WO2019094780A2 (en) | 2017-11-12 | 2018-11-09 | Non-coding rna for detection of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020004949A true MX2020004949A (es) | 2020-08-27 |
Family
ID=66439063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020004949A MX2020004949A (es) | 2017-11-12 | 2018-11-09 | Arn no codificante para la deteccion de cancer. |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20200362420A1 (https=) |
| EP (1) | EP3707259A4 (https=) |
| JP (3) | JP7549880B2 (https=) |
| CN (1) | CN111344409A (https=) |
| AU (2) | AU2018364987A1 (https=) |
| CA (1) | CA3082391A1 (https=) |
| MX (1) | MX2020004949A (https=) |
| WO (1) | WO2019094780A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018136936A1 (en) | 2017-01-23 | 2018-07-26 | Srnalytics, Inc. | Methods for identifying and using small rna predictors |
| WO2021102228A1 (en) * | 2019-11-21 | 2021-05-27 | Icahn School Of Medicine At Mount Sinai | Small unannotated, non-coding rnas for the detection of liver cancer |
| US20230063506A1 (en) * | 2020-01-22 | 2023-03-02 | Srnalytics, Inc. | Small rna disease classifiers |
| WO2022029488A1 (en) * | 2020-08-06 | 2022-02-10 | Agenda Nv | Systems and methods of assessing breast cancer |
| WO2022040106A2 (en) * | 2020-08-16 | 2022-02-24 | The Regents Of The University Of California | System and methods of detection of oncrnas for cancer diagnosis |
| US11954859B2 (en) | 2020-11-11 | 2024-04-09 | Agendia NV | Methods of assessing diseases using image classifiers |
| WO2023192227A2 (en) * | 2022-03-29 | 2023-10-05 | The Regents Of The University Of California | Methods for determining the presence, type, grade, classification of a tumor, cyst, lesion, mass, and/or cancer |
| WO2025033530A1 (ja) * | 2023-08-10 | 2025-02-13 | 国立大学法人山口大学 | 大腸癌の診断マーカー |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
| US20080076674A1 (en) * | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
| WO2008109556A1 (en) * | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting telomerase gene expression and uses thereof |
| US20110054009A1 (en) * | 2008-02-28 | 2011-03-03 | The Ohio State University Research Foundation | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders |
| US20110136124A1 (en) * | 2009-09-23 | 2011-06-09 | Wilson Roa | Microrna expression profiles associated with lung cancer |
| EP2388336A1 (en) * | 2010-05-19 | 2011-11-23 | Signature Diagnostics AG | Method and kits for diagnosing colorectal cancer |
| EP2640854B1 (en) * | 2010-11-19 | 2018-02-21 | The Regents Of The University Of Michigan | PCAT1 ncRNA AND USES THEREOF |
| BR112013033488B8 (pt) * | 2011-06-27 | 2022-11-22 | Eisai R&D Man Co Ltd | Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit |
| EP3492606B1 (en) * | 2011-08-22 | 2023-10-04 | Exosome Diagnostics, Inc. | Urine biomarkers |
| JP2014003925A (ja) | 2012-06-22 | 2014-01-16 | Japanese Foundation For Cancer Research | 予後不良の肺小細胞がんの検査方法及び治療手段 |
| WO2017190003A1 (en) * | 2016-04-28 | 2017-11-02 | Joslin Diabetes Center, Inc. | Compositions and method for treating and preventing end stage renal disease |
-
2018
- 2018-11-09 CA CA3082391A patent/CA3082391A1/en active Pending
- 2018-11-09 CN CN201880073234.5A patent/CN111344409A/zh active Pending
- 2018-11-09 WO PCT/US2018/060113 patent/WO2019094780A2/en not_active Ceased
- 2018-11-09 MX MX2020004949A patent/MX2020004949A/es unknown
- 2018-11-09 AU AU2018364987A patent/AU2018364987A1/en not_active Abandoned
- 2018-11-09 EP EP18876580.4A patent/EP3707259A4/en active Pending
- 2018-11-09 JP JP2020524429A patent/JP7549880B2/ja active Active
- 2018-11-09 US US16/763,540 patent/US20200362420A1/en not_active Abandoned
-
2022
- 2022-04-15 US US17/722,051 patent/US20220325359A1/en not_active Abandoned
-
2023
- 2023-10-02 JP JP2023171655A patent/JP2024009855A/ja active Pending
-
2024
- 2024-01-31 US US18/429,051 patent/US12398429B2/en active Active
- 2024-06-24 US US18/752,640 patent/US20250154598A1/en active Pending
-
2025
- 2025-06-27 AU AU2025204881A patent/AU2025204881B2/en active Active
- 2025-12-09 JP JP2025243921A patent/JP2026041956A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2025204881B2 (en) | 2025-10-02 |
| US20250101509A1 (en) | 2025-03-27 |
| JP7549880B2 (ja) | 2024-09-12 |
| WO2019094780A2 (en) | 2019-05-16 |
| US20220325359A1 (en) | 2022-10-13 |
| AU2025204881A1 (en) | 2025-07-17 |
| US20200362420A1 (en) | 2020-11-19 |
| JP2021502069A (ja) | 2021-01-28 |
| CN111344409A (zh) | 2020-06-26 |
| JP2026041956A (ja) | 2026-03-10 |
| WO2019094780A3 (en) | 2020-04-02 |
| CA3082391A1 (en) | 2019-05-16 |
| JP2024009855A (ja) | 2024-01-23 |
| EP3707259A2 (en) | 2020-09-16 |
| EP3707259A4 (en) | 2021-08-11 |
| US12398429B2 (en) | 2025-08-26 |
| AU2018364987A1 (en) | 2020-04-23 |
| US20250154598A1 (en) | 2025-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020004949A (es) | Arn no codificante para la deteccion de cancer. | |
| MX394474B (es) | Métodos de pronóstico para cáncer de vejiga sin invasión muscular y antagonistas para usarse en el tratamiento de lo mismo. | |
| MX2016011377A (es) | Metodo para diagnosticar cancer colorrectal a partir de una muestra de heces humanas por pcr cuantitativa, cebadores y equipo. | |
| MX2017003790A (es) | Detección de secuencias diana por percepción de nanoporos de sondas sintéticas. | |
| EP4495267A3 (en) | Breast cancer detection kit or device, and detection method | |
| BR112016029583A2 (pt) | ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção? | |
| BR112016029634A2 (pt) | kit, dispositivo e método para a detecção de câncer de fígado | |
| BR112016028944A2 (pt) | kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| EA201692157A1 (ru) | Синтез двухцепочечных нуклеиновых кислот | |
| MX2014004860A (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| MA39776A (fr) | Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf | |
| WO2015149034A3 (en) | Gene fusions and gene variants associated with cancer | |
| EA201590724A1 (ru) | Prdm14 и fam19a4, молекулярные диагностические маркеры для выявления впч-индуцируемых инвазивных раковых заболеваний и предшествующих им поражений высокой степени | |
| MX2017006075A (es) | Biomarcadores para la progresion de enfermedades en melanoma. | |
| WO2015179777A3 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| ES2548299B2 (es) | Firma de microARN como indicador del riesgo de recurrencia temprana en pacientes con cáncer de mama | |
| AR104413A1 (es) | Anticuerpo de igf-1r y su utilización para diagnosticar cáncer | |
| RU2010123021A (ru) | Способ диагностики рака молочной железы по уровню рнк интерлейкинов il-8 и/или il-18 в плазме крови | |
| GB2538006A (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| WO2015107430A3 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
| BR112016005413A2 (pt) | usos de pelo menos um mirna, kit, métodos de diagnóstico de câncer de mama e métodos para avaliação de risco de metástase | |
| MX348351B (es) | Oligonucleotidos de candida albicans, metodo de deteccion y kit de los mismos. | |
| WO2017129753A8 (en) | Means and methods for staging, typing and treating a cancerous disease | |
| RU2012113807A (ru) | Способ оценки функционального состояния эндотелия экспериментальных животных после реконструктивных операций на брюшной аорте |